Kura Oncology (KURA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $9.08, -6.39% vs the prior close of $9.70.
- Volume 1.78M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KURA slides 6.4% to $9.08, a 1-month low. Closed at $9.08, -6.39% vs the prior close of $9.70. Day range $9.05–$9.68, opened at $9.68.
KURA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — KURA slides 6.4% to $9.08, a 1-month low
- Closed at $9.08, -6.39% vs the prior close of $9.70. Day range $9.05–$9.68, opened at $9.68.
- Volume was 1.78M shares, 0.9x its 50-day average of 1.99M.
- Price is -19.8% vs its 50-day average ($11.32) and -7.2% vs its 200-day average ($9.79).
- 52-week range $7.36–$13.90; today's close sits at 26% of that range, 34.7% below the 52-week high.
Oct 15, 2026 — KURA rises 0.9% to $9.70
- Closed at $9.70, +0.94% vs the prior close of $9.61. Day range $9.60–$9.90, opened at $9.82.
- Volume was 1.68M shares, 0.8x its 50-day average of 1.98M.
- Price is -14.3% vs its 50-day average ($11.32) and -1.0% vs its 200-day average ($9.80).
- 52-week range $7.36–$13.90; today's close sits at 36% of that range, 30.2% below the 52-week high.
Oct 14, 2026 — KURA dips 2.2% to $9.61, a 1-month low, 3 down days in a row
- Closed at $9.61, -2.24% vs the prior close of $9.83. Day range $9.57–$9.86, opened at $9.70.
- Volume was 1.83M shares, 0.9x its 50-day average of 1.97M.
- Price is -15.1% vs its 50-day average ($11.31) and -1.9% vs its 200-day average ($9.80).
- 52-week range $7.36–$13.90; today's close sits at 34% of that range, 30.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — KURA slides 5.4% to $9.83, a 1-month low
- Closed at $9.83, -5.44% vs the prior close of $10.40. Day range $9.76–$10.29, opened at $10.29.
- Volume was 2.71M shares, 1.4x its 50-day average of 1.94M.
- Price is -13.1% vs its 50-day average ($11.31) and +0.3% vs its 200-day average ($9.80).
- 52-week range $7.36–$13.90; today's close sits at 38% of that range, 29.3% below the 52-week high.
Oct 12, 2026 — KURA dips 1.9% to $10.40, a 1-month low
- Closed at $10.40, -1.93% vs the prior close of $10.60. Day range $10.31–$10.68, opened at $10.60.
- Volume was 1.21M shares, 0.6x its 50-day average of 1.94M.
- Price is -8.0% vs its 50-day average ($11.30) and +6.0% vs its 200-day average ($9.81).
- 52-week range $7.36–$13.90; today's close sits at 46% of that range, 25.2% below the 52-week high.
Oct 9, 2026 — KURA rises 0.8% to $10.60
- Closed at $10.60, +0.76% vs the prior close of $10.52. Day range $10.38–$10.68, opened at $10.52.
- Volume was 1.47M shares, 0.8x its 50-day average of 1.93M.
- Price is -5.9% vs its 50-day average ($11.27) and +8.0% vs its 200-day average ($9.81).
- 52-week range $7.36–$13.90; today's close sits at 50% of that range, 23.7% below the 52-week high.
Oct 8, 2026 — KURA dips 1.4% to $10.52, a 1-month low
- Closed at $10.52, -1.41% vs the prior close of $10.67. Day range $10.16–$10.55, opened at $10.52.
- Volume was 1.64M shares, 0.8x its 50-day average of 1.94M.
- Price is -6.4% vs its 50-day average ($11.24) and +7.2% vs its 200-day average ($9.82).
- 52-week range $7.36–$13.90; today's close sits at 48% of that range, 24.3% below the 52-week high.
Oct 7, 2026 — KURA rises 1.3% to $10.67
- Closed at $10.67, +1.33% vs the prior close of $10.53. Day range $10.32–$10.99, opened at $10.43.
- Volume was 1.10M shares, 0.6x its 50-day average of 1.95M — lighter than usual.
- Price is -4.8% vs its 50-day average ($11.21) and +8.7% vs its 200-day average ($9.81).
- 52-week range $7.36–$13.90; today's close sits at 51% of that range, 23.2% below the 52-week high.
Oct 6, 2026 — KURA dips 0.8% to $10.53, a 1-month low, 5 down days in a row
- Closed at $10.53, -0.85% vs the prior close of $10.62. Day range $10.34–$10.89, opened at $10.75.
- Volume was 1.30M shares, 0.7x its 50-day average of 1.94M.
- Price is -5.9% vs its 50-day average ($11.19) and +7.4% vs its 200-day average ($9.81).
- 52-week range $7.36–$13.90; today's close sits at 48% of that range, 24.2% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 — KURA ends flat (-0.3%) to $10.62, 4 down days in a row
- Closed at $10.62, -0.28% vs the prior close of $10.65. Day range $10.29–$10.80, opened at $10.73.
- Volume was 1.29M shares, 0.7x its 50-day average of 1.94M.
- Price is -5.0% vs its 50-day average ($11.18) and +8.3% vs its 200-day average ($9.81).
- 52-week range $7.36–$13.90; today's close sits at 50% of that range, 23.6% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — KURA ends flat (+0.0%) to $10.65, 3 down days in a row
- Closed at $10.65, +0.00% vs the prior close of $10.65. Day range $10.59–$10.97, opened at $10.85.
- Volume was 1.89M shares, 1.0x its 50-day average of 1.92M.
- Price is -4.7% vs its 50-day average ($11.17) and +8.6% vs its 200-day average ($9.81).
- 52-week range $7.36–$13.90; today's close sits at 50% of that range, 23.4% below the 52-week high.
- That makes 3 straight losses.
KURA latest news & SEC filings
Every SEC filing by or about KURA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bair Teresa Brophy sold 8,442 shares at $10.50 (≈$88.62K) on Sep 28, 2026; now holds 187,002
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ford Kathleen sold 6,906 shares at $10.50 (≈$72.49K) on Sep 28, 2026; now holds 146,654
- Ford Kathleen sold 3,668 shares at $10.75 (≈$39.44K) on Sep 29, 2026; now holds 142,986
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Leoni Mollie sold 12,448 shares at $10.50 (≈$130.67K) on Sep 28, 2026; now holds 169,897
- Leoni Mollie sold 28,802 shares at $10.75 (≈$309.57K) on Sep 29, 2026; now holds 141,095
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Doyle Thomas James sold 4,607 shares at $10.50 (≈$48.36K) on Sep 28, 2026; now holds 142,428
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Powl Brian T. sold 9,020 shares at $10.50 (≈$94.69K) on Sep 28, 2026; now holds 160,249
- Powl Brian T. sold 8,000 shares at $10.56 (≈$84.50K) on Sep 28, 2026; now holds 152,249
- Powl Brian T. sold 15,430 shares at $10.75 (≈$165.85K) on Sep 29, 2026; now holds 136,819
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $20.87M (prior year $15.29M) (+36.5% vs Jun 30, 2025)
- Net income: -$68.33M (prior year -$66.12M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.77 (prior year -$0.75) (loss widened vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade KURA
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 5, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.84% (largest 6.4%).
- Liquidity: about 1.75M shares (≈$15.87M) trade per day on average.
- 52-week position: $9.08 vs a range of $7.36–$13.90 (26% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Mollie Leoni sold 28,802 shares on Sep 29, 2026.
- Latest filings: 8-K Sep 9, 2026; 8-K Sep 8, 2026; 10-Q Aug 12, 2026.
- Share count: 88.96M shares outstanding (Aug 7, 2026), +2.5% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
KURA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9.68 | 9.68 | 9.05 | 9.08 | 1.78M |
| Oct 15, 2026 | 9.82 | 9.90 | 9.60 | 9.70 | 1.68M |
| Oct 14, 2026 | 9.70 | 9.86 | 9.57 | 9.61 | 1.83M |
| Oct 13, 2026 | 10.29 | 10.29 | 9.76 | 9.83 | 2.71M |
| Oct 12, 2026 | 10.60 | 10.68 | 10.31 | 10.40 | 1.21M |
| Oct 9, 2026 | 10.52 | 10.68 | 10.38 | 10.60 | 1.47M |
| Oct 8, 2026 | 10.52 | 10.55 | 10.16 | 10.52 | 1.64M |
| Oct 7, 2026 | 10.43 | 10.99 | 10.32 | 10.67 | 1.10M |
| Oct 6, 2026 | 10.75 | 10.89 | 10.34 | 10.53 | 1.30M |
| Oct 5, 2026 | 10.73 | 10.80 | 10.29 | 10.62 | 1.29M |
| Oct 2, 2026 | 10.85 | 10.97 | 10.59 | 10.65 | 1.89M |
| Oct 1, 2026 | 11.10 | 11.12 | 10.59 | 10.65 | 2.43M |
| Sep 30, 2026 | 10.90 | 10.95 | 10.60 | 10.71 | 1.87M |
| Sep 29, 2026 | 10.65 | 10.90 | 10.54 | 10.81 | 1.89M |
| Sep 28, 2026 | 10.71 | 10.83 | 10.36 | 10.61 | 1.65M |
| Sep 25, 2026 | 10.88 | 10.96 | 10.75 | 10.76 | 1.23M |
| Sep 24, 2026 | 11.00 | 11.07 | 10.66 | 10.86 | 1.77M |
| Sep 23, 2026 | 11.73 | 11.81 | 10.82 | 11.04 | 2.77M |
| Sep 22, 2026 | 11.80 | 11.98 | 11.59 | 11.73 | 1.68M |
| Sep 21, 2026 | 11.86 | 12.00 | 11.49 | 11.60 | 1.76M |
About Kura Oncology
Kura Oncology (KURA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1422143.
KURA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Helen Louise Collins | Director | Jun 4, 2026 |
| Faheem Hasnain | Director | Jun 4, 2026 |
| Thomas Malley | Director | Jun 4, 2026 |
| Diane L. Parks | Director | Jun 4, 2026 |
| Carol Schafer | Director | Jun 4, 2026 |
| Mary T Szela | Director | Jun 4, 2026 |
| Michael Vasconcelles | Director | Jun 4, 2026 |
| Troy Edward Wilson | President and CEO | Aug 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Teresa Brophy Bair | Chief Legal Officer | Sep 29, 2026 |
| Francis Burrows | Chief Scientific Officer | Sep 25, 2026 |
| Thomas James Doyle | SVP, Finance & Accounting | Sep 29, 2026 |
| Kathleen Ford | Chief Operating Officer | Sep 29, 2026 |
| Jennifer Fulk | Chief Financial Officer | Sep 10, 2026 |
| Mollie Leoni | Chief Medical Officer | Sep 29, 2026 |
| Brian T. Powl | Chief Commercial Officer | Sep 29, 2026 |
| Troy Edward Wilson | President and CEO | Aug 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 29, 2026 | Mollie Leoni | Sale | 28,802 | $10.75 |
| Sep 29, 2026 | Mollie Leoni | Sale | 28,802 | $10.75 |
| Sep 29, 2026 | Mollie Leoni | Sale | 28,802 | $10.75 |
| Sep 29, 2026 | Mollie Leoni | Sale | 28,802 | $10.75 |
| Sep 29, 2026 | Kathleen Ford | Sale | 3,668 | $10.75 |
| Sep 29, 2026 | Kathleen Ford | Sale | 3,668 | $10.75 |
| Sep 29, 2026 | Kathleen Ford | Sale | 3,668 | $10.75 |
| Sep 29, 2026 | Kathleen Ford | Sale | 3,668 | $10.75 |
| Sep 29, 2026 | Brian T. Powl | Sale | 15,430 | $10.75 |
| Sep 29, 2026 | Brian T. Powl | Sale | 15,430 | $10.75 |
| Sep 29, 2026 | Brian T. Powl | Sale | 15,430 | $10.75 |
| Sep 29, 2026 | Brian T. Powl | Sale | 15,430 | $10.75 |
| Sep 28, 2026 | Mollie Leoni | Sale | 12,448 | $10.50 |
| Sep 28, 2026 | Mollie Leoni | Sale | 12,448 | $10.50 |
| Sep 28, 2026 | Mollie Leoni | Sale | 12,448 | $10.50 |
KURA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $67.48M | $-278.67M | -3.18 | $-64.06M |
| Dec 31, 2024 | $53.88M | $-173.98M | -2.02 | $134.32M |
| Dec 31, 2023 | $0 | $-152.63M | -2.08 | $-124.82M |
| Dec 31, 2022 | — | $-135.84M | -2.03 | $-110.06M |
| Dec 31, 2021 | — | $-130.47M | -1.97 | $-104.55M |
Latest balance sheet: total assets $587.79M, total liabilities $539.36M, cash $70.24M (as of Jun 30, 2026).
KURA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $9.94 |
| May 12, 2026 | 8-K Item 2.02 (results) | $9.68 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $8.51 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $9.17 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $9.96 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $5.96 |
| May 1, 2025 | 8-K Item 2.02 (results) | $6.49 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $7.77 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $17.77 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on KURA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.